Where does Biosight Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Biosight Ltd. ranks #45,209 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Biosight Ltd. hold?

Biosight Ltd. holds 5 US utility patents granted between 2015 and 2024, spanning 3 technology areas.

What is Biosight Ltd.'s Innovation Score?

Biosight Ltd. has an Innovation Score of 26.8 out of 100 (21st percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Biosight Ltd. focus on?

Biosight Ltd.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 5 patents, ranking #3,434 of 6,058 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

Is Biosight Ltd.'s patent grant rate increasing or decreasing?

Biosight Ltd.'s recent grant velocity is +300% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Biosight Ltd.'s patents?

Biosight Ltd.'s patents average 13.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Biosight Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Biosight Ltd.

USPTO PatentsView assignee record - 5 granted patents across 3 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Biosight ranks #45,209 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 3 technology areas.

#45,209
of 49,997 US assignees by volume: 21st percentile
by Innovation Score (26.8/100): 13.0
avg claims per patent: +300%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R45209 · Foreign Corporation #45,209 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #45,209/49,997
PHOTO-FINISH Biomed Device S R L
CPC-NARROW A61P · 3 areas
INNOV-THIN 26.8/100
CLAIMS-RICH 13.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +300% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Biomed Device S.R.L. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Biosight’s 26.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (23%) Velocity 6.7 pts (25%) Breadth 6.1 pts (23%) Claim depth 7.8 pts (29%)

Qualcomm Incorporated · highest

85
Autel NEW Energy · near

27
BugMD · near

27
Dongguan DaXianGuang… · near

27
Biosight · this assignee

27
DR Hahn & KG · near

27
3D Lighting… · lowest

7

What this shows Biosight's Innovation Score is 26.8/100 (21st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Biosight?

Each dot is one of Biosight’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biosight’s own 13.0 claims/patent is at or below the 15.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Biosight vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Biosight's grants concentrate

Biosight Ltd. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2021 (2 grants) versus a trough of 1 in 2015. By volume, Biosight sits between Biomed Device S.R.L. and BitTorrent, Inc..

Biosight's three-year grant acceleration

Biosight Ltd. shows 2 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Biomed Device S R…

5
Bionano Health Gu…

5
Biopico Systems

5
Biorchestra

5
Bird Control Grou…

5
Bisa Trading Pty

5
Bitfury Group

5
Bittorrent

5
Biosight ◀

5

What this shows Biosight holds 5 patents at rank #45,306, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Biosight

By rank, the assignees closest to #45,306 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Biosight's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Biosight, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Biosight ranks #3,434 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (27 here).

DR. Hahn GMBH & Co. KG 27 BugMD LLC 27 Autel NEW Energy Co., Ltd. 27 Dongguan DaXianGuang Lighting Technology Co., Ltd. 27

Biosight's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 21st percentile higher than 21% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Biosight Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	20.0%
2021	2	40.0%
2024	2	40.0%

Which technologies does Biosight Ltd. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 4

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 2

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Biosight Ltd.'s patent record in context - here's where to go next.

Biosight Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #45,209 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Biosight Ltd. against Biomed Device S.R.L., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 26.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.